{
    "Trade/Device Name(s)": [
        "VITEK\u00ae 2 Streptococcus Inducible Clindamycin Resistance",
        "VITEK\u00ae 2 AST-ST Inducible Clindamycin Resistance"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K111909",
    "Predicate Device Reference 510(k) Number(s)": [
        "K080201"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "October 17, 2011",
    "Summary Letter Received Date": "October 17, 2011",
    "Submission Date": "June 30, 2011",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Short-Term Antimicrobial Susceptibility Test System"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Streptococcus agalactiae",
        "Streptococcus pyogenes"
    ],
    "Specimen Type(s)": [
        "Isolated colonies"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITEK\u00ae 2",
        "VITEK\u00ae 2 Compact"
    ],
    "Method(s)/Technology(ies)": [
        "Automated susceptibility testing",
        "Qualitative test",
        "Microdilution methodology"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing",
        "Minimum inhibitory concentration (MIC) determination"
    ],
    "Submission Type(s)": [
        "Test"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK\u00ae 2 Streptococcus Inducible Clindamycin Resistance automated qualitative susceptibility test for Streptococcus agalactiae and Streptococcus pyogenes.",
    "Indications for Use Summary": "Designed for antimicrobial susceptibility testing of Streptococcus agalactiae and Streptococcus pyogenes as a laboratory aid in determining in vitro susceptibility to antimicrobial agents using VITEK\u00ae 2 and VITEK\u00ae 2 Compact Systems.",
    "fda_folder": "Microbiology"
}